- Home
- ZKH vs CATX Comparison
ZKH vs CATX Comparison
Compare ZKH & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZKH | CATX |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.8M | 497.9M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ZKH | CATX |
|---|---|---|
| Price | $2.83 | $4.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 338.4K | ★ 1.3M |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.02 | N/A |
| Revenue Next Year | $10.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $1.96 |
| 52 Week High | $3.90 | $6.16 |
Technical Indicators
Market Signals| Indicator | ZKH | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 58.26 |
| Support Level | $2.83 | $3.93 |
| Resistance Level | $3.12 | $4.61 |
| Average True Range (ATR) | 0.16 | 0.25 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 58.06 | 92.68 |
Price Performance
Historical ComparisonAbout ZKH ZKH Group Limited
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.